Clinical Trials Directory

Trials / Completed

CompletedNCT02235103

The Predictive Value of the Sperm Chromatin Dispersion Test, Halosperm®, Before and After Sperm Preparation for Clinical Pregnancy in Cases of Unexplained Infertility Treated With Intra-uterine Insemination (First Cycle) and Ovulation Induction With Clomiphene Citrate.

Status
Completed
Phase
Study type
Observational
Enrollment
21 (actual)
Sponsor
University Hospital, Ghent · Academic / Other
Sex
All
Age
18 Years – 40 Years
Healthy volunteers
Not accepted

Summary

Recent research has revealed that subtle abnormalities can be found in sperm samples that seem to be normal with conventional analysis techniques. The DNA in the sperm heads is sometimes fragmented and this may be the reason why couples with a diagnosis of unexplained infertility do not achieve pregnancy. We are planning a study to examine the incidence of DNA fragmentation in the sperm of couples with previously unexplained infertility. In a first treatment cycle with intra-uterine insemination the percentage of DNA fragmentation in sperm will be measured. Afterwards the results of the patients who are pregnant will be compared with those of the not pregnant ones. We expect to find differences between both groups. 100 patients will be included in the study.

Conditions

Interventions

TypeNameDescription
OTHERSperm Chromatin Dispersion Test

Timeline

Start date
2014-04-01
Primary completion
2016-03-01
Completion
2016-03-01
First posted
2014-09-09
Last updated
2016-03-14

Locations

1 site across 1 country: Belgium

Source: ClinicalTrials.gov record NCT02235103. Inclusion in this directory is not an endorsement.